EPS Creative Health Technology Group Limited (3860.HK)
HKD 0.51
(-5.56%)
HKD 0.51
(-5.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -31.91 Million | -38.1 Million | 10.04 Million | -12.38 Million | 24.64 Million | 3.95 Million |
| Net Income | -22.06 Million | -48.16 Million | -16.62 Million | 7.13 Million | 27.8 Million | 32.72 Million |
| Depreciation & Amortization | 14.01 Million | 4.48 Million | 3.46 Million | 3.03 Million | 2.2 Million | 1.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.08 Million | 765 Thousand | 16.78 Million | -17.21 Million | 1.41 Million | -26.19 Million |
| Other non-cash items | 15.96 Million | 4.8 Million | 6.41 Million | -5.33 Million | -6.77 Million | -3.66 Million |
| Investing Cash Flow | -21.49 Million | -11.38 Million | 4.56 Million | -234 Thousand | 6.68 Million | -1.64 Million |
| Investments in PPE | -5.03 Million | -2.4 Million | -54 Thousand | -525 Thousand | -343 Thousand | -2.94 Million |
| Acquisitions | -16.45 Million | - | 2.05 Million | 180 Thousand | - | - |
| Investment purchases | - | - | -3.54 Million | - | - | - |
| Sales/Maturities of investments | - | - | -2.05 Million | - | - | - |
| Other Investing Activities | 1.09 Million | -8.97 Million | 8.16 Million | 111 Thousand | 7.03 Million | 1.29 Million |
| Financing Cash Flow | 38.1 Million | -27.75 Million | 98.1 Million | -1.81 Million | -9.38 Million | -7.73 Million |
| Debt repayment | -7.33 Million | -18.26 Million | -1.63 Million | -10.44 Million | -15.23 Million | -16.17 Million |
| Dividends payments | - | - | - | - | -8 Million | -7.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 34.13 Million | -9.48 Million | 99.73 Million | 8.63 Million | 13.84 Million | 15.93 Million |
| Accounts receivables | -9.97 Million | -4.16 Million | 12.83 Million | -3.89 Million | 140 Thousand | -14.09 Million |
| Accounts payables | -3.34 Million | -1.75 Million | 7.17 Million | -11.95 Million | -577 Thousand | 2.82 Million |
| Inventory | 8.6 Million | 2.77 Million | -3.44 Million | -1.37 Million | -1.2 Million | 811 Thousand |
| Other working capital | -2.37 Million | 3.9 Million | 227 Thousand | 11.45 Million | 3.05 Million | -15.73 Million |
| Cash at beginning of period | 140.47 Million | 208.14 Million | 85.23 Million | 99.5 Million | 77.68 Million | 83.35 Million |
| Cash at end of period | 124.54 Million | 131.47 Million | 197.95 Million | 85.23 Million | 99.5 Million | 77.68 Million |
| Capital Expenditure | -5.03 Million | -2.4 Million | -54 Thousand | -525 Thousand | -343 Thousand | -2.94 Million |
| Effect of forex changes on cash | -622 Thousand | 575 Thousand | -2000.00 | 160 Thousand | -133 Thousand | -236 Thousand |
| Net cash flow / Change in cash | -15.93 Million | -76.67 Million | 112.71 Million | -14.26 Million | 21.81 Million | -5.66 Million |
| Free Cash Flow | -36.95 Million | -40.51 Million | 9.99 Million | -12.9 Million | 24.3 Million | 1.01 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.06 Million | -8.41 Million | -8.41 Million | -5.23 Million | -2.61 Million | -48.16 Million |
| Depreciation & Amortization | 14.01 Million | 4.4 Million | 4.4 Million | 5.21 Million | 2.6 Million | 4.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.08 Million | 12.88 Million | 12.88 Million | 4.33 Million | -13.56 Million | 765 Thousand |
| Other non-cash items | 15.96 Million | -25.76 Million | -25.76 Million | 3.65 Million | 16.19 Million | 4.8 Million |
| Investing Cash Flow | -21.49 Million | -9.63 Million | -9.63 Million | -1.89 Million | -566 Thousand | -11.38 Million |
| Investments in PPE | -5.03 Million | -1.57 Million | -1.57 Million | -1.89 Million | -946 Thousand | -2.4 Million |
| Acquisitions | -16.45 Million | -8.22 Million | -8.22 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.09 Million | 165 Thousand | 165 Thousand | 380 Thousand | 380 Thousand | -8.97 Million |
| Financing Cash Flow | 38.1 Million | 18.1 Million | 18.1 Million | -832 Thousand | -1.27 Million | -27.75 Million |
| Debt repayment | -7.33 Million | -191 Thousand | - | -698 Thousand | - | -18.26 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 34.13 Million | 18.1 Million | 18.1 Million | 2.24 Million | -1.27 Million | -9.48 Million |
| Accounts receivables | -9.97 Million | 7.05 Million | 7.05 Million | -24.09 Million | -12.04 Million | -4.16 Million |
| Accounts payables | -3.34 Million | -37.22 Million | - | 33.88 Million | - | -1.75 Million |
| Inventory | 8.6 Million | 5.82 Million | 5.82 Million | -3.04 Million | -1.52 Million | 2.77 Million |
| Other working capital | -2.37 Million | 33 Thousand | - | -2.41 Million | - | 3.9 Million |
| Cash at beginning of period | 140.47 Million | 141.5 Million | - | 140.47 Million | - | 208.14 Million |
| Cash at end of period | 124.54 Million | 124.54 Million | -8.48 Million | 141.5 Million | 518 Thousand | 131.47 Million |
| Capital Expenditure | -5.03 Million | -1.57 Million | -1.57 Million | -1.89 Million | -946 Thousand | -2.4 Million |
| Effect of forex changes on cash | -622 Thousand | -52.5 Thousand | -52.5 Thousand | -258.5 Thousand | -258.5 Thousand | 575 Thousand |
| Net cash flow / Change in cash | -15.93 Million | -16.96 Million | -8.48 Million | 1.03 Million | 518 Thousand | -76.67 Million |
| Free Cash Flow | -36.95 Million | -18.47 Million | -18.47 Million | 2.38 Million | 1.67 Million | -40.51 Million |
3169
600883
MKA
7256
MATW
ABA